AzTrials
AzTrials

Proximal Femur FractureNCT04309539

Which Analgesia is Better for Proximal Femoral Fractures?

A study testing Fascia iliaca block and combined LFCN block with PENG block in people with Proximal Femur Fracture, run by Mansoura University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This patient population is typically elderly and frail. They are at risk of adverse effects secondary to inadequate pain management such as prolonged admissions and poor functional outcomes. Read more about this study

Who is it for?
Ages 50 to 90 years
Conditions the study is for
Proximal Femur Fracture
What is being tested?
Fascia iliaca block and combined LFCN block with PENG block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
21 Sep 2020to Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 90 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • American Society of Anesthesiologists (ASA) physical status I, II and III.

Who cannot join

  • Patient refusal.
  • Neuromuscular diseases
  • Hematological diseases
  • Bleeding abnormality
  • Coagulation abnormality.
  • Psychiatric diseases.
Show all 11Show fewer
  • Local skin infection at the site of the block.
  • Local skin sepsis at the site of the block
  • Known intolerance to the study drugs.
  • Body Mass Index > 40 Kg/m2.
  • Multiple trauma patients.

Trial locations and contacts

1 site in 1 country.

Mona A Hasheesh, MD contact

00201027034020

drmonahasheesh@hotmail.com

Eiad A Ramzy, MD contact

00201005774079

eiadramzy@yahoo.com

Egypt1 site, 1 recruiting
  • Mansoura University, emergency hospital

    Al Mansurah, DK, 050

    Mona A Hasheesh, MD, 00201027034020, drmonahasheesh@hotmail.com

    Eyad A Ramzy, MD, 00201005774079, eiadramzy@yahoo.com

    Recruiting

Other trials in Egypt

About this study

Official title: - Efficacy of Combined Lateral Femoral Cutaneous Nerve Block With Pericapsular Nerve Group Block Versus Fascia Iliaca Block in Proximal Femoral Fractures

This patient population is typically elderly and frail. They are at risk of adverse effects secondary to inadequate pain management such as prolonged admissions and poor functional outcomes.

Regional analgesia is preferred due to their opioid-sparing effects and reduction in related adverse effects but The analgesia from these blocks is only moderate and literature suggests that the obturator nerve (ON) is not covered.

Read the detailed description

The aim of this study is to compare the effect of combined lateral femoral cutaneous nerve block with pericapsular nerve group block versus fascia iliaca block for proximal femur surgery.

Fascia iliaca compartment block is a simple technique to manage pain before positioning for spinal anesthesia performance and it constitutes a practical choice for perioperative pain control.

A recent anatomical study confirmed the innervation of the anterior hip by these 3 main nerves, but also found that the AON and FN play a greater role in the anterior hip innervation than previously reported The high articular branches from FN and AON are consistently found between the anterior inferior iliac spine (AIIS) and the iliopubic eminence (IPE), whereas the ON is located close to the inferomedial acetabulum.

The ultrasound-guided technique for blockade of these articular branches to the hip, the PENG (Pericapsular Nerve Group) block reported significantly reduced pain scores compared with baseline. Roy et al 2019 recommended the use of PENG block together with LFCN block as adjunctive to cover the lateral surgical incision.

Being tested
Fascia iliaca block, combined LFCN block with PENG block
Medical subject headings
Proximal Femoral Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fascia iliaca blockProcedure or surgery

    A linear probe will be placed in the sagittal plane to the inguinal ligament to obtain an image of "bow-tie sign" formed by the muscle fascias, a spinal needle will be inserted 1 cm cephalad Using an in-plane approach, the fascia iliaca is penetrated, 30 mL of bupivacaine 0.25% before spinal anesthesia.

  • combined LFCN block with PENG blockProcedure or surgery

    With the patient supine, the linear probe is placed parallel to the inguinal ligament. LFCN appear as a hypoechoic oval structure between the tensor fascia lata and Sartorius muscles. The needle is inserted in plane. 5 mL of LA is injected. The PENG block will be performed in the supine position. A curvilinear probe will be placed transversely over the anterior inferior iliac spine and then rotated counterclockwise 45 degrees. the ilio pubic eminence, the iliopsoas muscle and tendon, the femoral artery, and pectineus muscle will be observed. A spinal needle will be inserted in plane to the plane between the psoas tendon and the pubic ramus. 25 mL of bupivacaine 0.25% will be injected

Study groups in NCT04309539
Study groupRoleWhat they receive
Fascia iliaca blockActive comparatorPatients will receive Fascia iliaca block
Receives: Procedure: Fascia iliaca block
combined LFCN block with PENG blockActive comparatorPatients will receive a combined lateral femoral cutaneous nerve block with pericapsular nerve group block
Receives: Procedure: combined LFCN block with PENG block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time of performance of Spinal Anesthesia

    Is defined as the time measured from the start of positioning to the completion of the intrathecal bupivacaine injection

    Measured: just before surgery.

Secondary outcomes (18)
  1. Pain measurement at rest

    10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain

    Measured: immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.

  2. Pain measurement on movement

    (attempted hip flexion to 15 degrees).: 10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain

    Measured: immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.

  3. Pain measurement during positioning for spinal anesthesia

    visual analog scale (0-10, 0: no pain, 10: worst pain imaginable) during changing position from supine to sitting one

    Measured: Just before surgery

  4. The severity of postoperative pain at rest

    10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain

    Measured: immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.

  5. The severity of postoperative pain on movement

    (attempted hip flexion to 15 degrees): 10-cm visual analog scale (VAS) for pain, where 0 is equal to no pain and 10 indicates the worst possible pain

    Measured: immediately and 1 hour at PACU, then in the surgical ward at 2,4,6,8,12,18 and 24 h after surgery.

  6. Time to onset of Sensory blockade

    cold perception loss in the lateral, anterior and medial part of the thigh (corresponding to lateral femoral cutaneous (LFC), femoral (F) and obturator (O)nerve sensory distributions, respectively)

    Measured: evaluated 15 and 30 min after block administration

  7. Time to onset of motor block

    defined as assessment of quadriceps femoris muscle strength by straight leg raise test to 15 degree and classified as follow: +ve =normal power, -ve =motor weakness

    Measured: evaluated 15 and 30 min after block administration

  8. Duration of sensory block

    blockade is defined as the interval between end of injection and complete end of sensory block (score=2)

    Measured: postoperative 24 hours

  9. Duration of motor block

    blockade is defined as the interval between end of injection and complete end of injection and complete recovery of normal motor function (score=0),

    Measured: postoperative 24 hours

  10. Anesthesiology satisfaction for patient positioning

    evaluated as 0=unsatisfactory, 1=satisfactory, 2=good or 3=optimal

    Measured: just before surgery

  11. heart rate

    Changes in heart rate

    Measured: pre-block, 15, 30 min after block, immediately after spinal anesthesia, 5min, 15min then every 30 min till end of surgery

  12. Mean arterial blood pressure

    Changes in Mean arterial blood pressure

    Measured: pre-block, 15, 30 min after block, immediately after spinal anesthesia, 5min, 15min then every 30 min till end of surgery

  13. Peripheral oxygen saturation

    Changes in peripheral oxygen saturation as measured with pulse oximetry

    Measured: pre-block, 15, 30 min after block, immediately after spinal anesthesia, 5min, 15min then every 30 min till end of surgery

  14. Time for first analgesic request

    defined as the time period from end of injection to the first time patient requests analgesia postoperatively

    Measured: Within 24 hours after surgery

  15. Total analgesics received

    cumulative consumption of opioids during the first postoperative day

    Measured: for 24 hrs after surgery

  16. Pruritis

    number of patients with pruritis

    Measured: Within 24 hours after surgery

  17. nausea

    number of patients with nausea

    Measured: Within 24 hours after surgery

  18. vomiting

    number of patients with vomiting

    Measured: Within 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Mar 2020
  2. Study start21 Sep 2020
  3. Primary completionJun 2021 (estimated)
  4. Study completionMar 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04309539
Sponsor's protocol ID
MFM-IRB, MD.20.02.280
Status last verified
Sep 2020
First submitted
12 Mar 2020
Last updated
23 Sep 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Yes, Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR)

Questions about this trial

What is this clinical trial studying?

A study testing Fascia iliaca block and combined LFCN block with PENG block in people with Proximal Femur Fracture, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mona A Hasheesh, MD (00201027034020, drmonahasheesh@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time of performance of Spinal Anesthesia (time frame: just before surgery.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in